Metallic elements in exhaled breath condensate of patients with interstitial lung diseases

Journal of Breath Research

Volumn 3, Issue 4, 2009, Pages

  Corradi, Massimo ^a   Acampa, Olga ^a   Goldoni, Matteo ^a   Adami, Elena ^a   Apostoli, Pietro ^b   De Palma, Giuseppe ^b   Pesci, Alberto ^c   Mutti, Antonio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; COBALT; COPPER; CORTICOSTEROID; HYDROXYCHLOROQUINE SULFATE; IMMUNOSUPPRESSIVE AGENT; NICKEL; PIRFENIDONE; SELENIUM; SILICON; TOBACCO SMOKE; TRACE ELEMENT; TRANSITION ELEMENT; ZINC;

ADULT; ARTICLE; BREATH ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; DISEASE SEVERITY; EXPIRED AIR; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG FUNCTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 76649139506     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/3/4/046003     Document Type: Article

References (40)

1. King T E 2005 Clinical advances in the diagnosis and therapy of the interstitial lung diseases Am. J. Respir. Crit. Care Med. 172 268-79
2. American Thoracic Society/European Respiratory Society 2002 International multidisciplinary consensus classification of the idiopathic interstitial pneumonias Am. J. Respir. Crit. Care Med. 165 277-304
3. British Thoracic Society and Standards of Care Committee 1999 The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults Thorax 54 (Suppl 1) S1-S30
4. Demedts M et al 2001 Interstitial lung diseases: an epidemiological overview Eur. Respir. J. 18 (Suppl 32) 2s-16s (Pubitemid 34755182)
5. Thomeer M J, Costabel U, Rizzato G, Poletti V and Demedts M 2001 Comparison of registries of interstitial lung diseases in three European countries Eur. Respir. J. 18 (Suppl. 32) 114s-8s
6. Lynch J P, Ma Y L, Koss M N and White E S 2007 Pulmonary sarcoidosis Semin. Respir. Crit. Care Med. 28 53-74
7. Judson M A 2008 Sarcoidosis: clinical presentation, diagnosis, and approach to treatment Am. J. Med. Sci. 335 26-33
8. Verleden G M et al 2001 Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Eur. Respir. J. 18 (Suppl. 32) 17s-29s
9. Steele M P and Brown K K 2007 Genetic predisposition to respiratory diseases: infiltrative lung diseases Respiration 74 601-8
10. Taskar V and Coultas D 2008 Exposures and idiopathic lung disease Semin. Respir. Crit. Care Med. 29 670-9
11. Taskar V S and Coultas D B 2006 Is idiopathic pulmonary fibrosis an environmental disease? Proc. Am. Thorac. Soc. 3 293-8
12. Baumgartner K B, Samet J M, Stidley C A, Colby T V and Waldron J A 1997 Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 155 242-8
13. Hubbard R, Lewis S, Richards K, Johnston I and Britton J 1996 Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis Lancet 347 284-9 (Pubitemid 26041039)
14. Baumgartner K B, Samet J M, Coultas D B, Stidley C A, Hunt W C, Colby T V and Waldron J A 2000 Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study Am. J. Epidemiol. 152 307-15
15. Miyake Y et al 2005 Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan Ann. Occup. Hyg. 49 259-65 (Pubitemid 40547331)
16. Pinheiro G A, Antao V C, Wood J M and Wassel J T 2008 Occupational risk for idiopathic fibrosis mortality in the United States Int. J. Occup. Environ. Health 14 117-23
17. Newman L S et al ACCESS Research Group 2004 A case control etiologic study of sarcoidosis: environmental and occupational risk factors Am. J. Respir. Crit. Care Med. 170 1324-30
18. Barnard J et al ACCESS Research Group 2005 Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS) J. Occup. Environ. Med. 47 226-34
19. Kharitonov S A and Barnes P J 2006 Exhaled biomarkers Chest 130 1541-6
20. Antczak A and Górski P 2002 Markers of pulmonary diseases in exhaled breath condensate Int. J. Occup. Med. Environ. Health 15 317-23
21. Mutti A, Corradi M, Goldoni M, Vettori M V, Bernard A and Apostoli P 2006 Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma Chest 129 1288-97
22. Maniscalco M, De Laurentiis G, Pentella C, Mormile M, Sanduzzi A, Carrat P and Sofia M 2006 Exhaled breath condensate as matrix for toluene detection: a preliminary study Biomarkers 11 233-40
23. Goldoni M, Catalani S, De Palma G, Manini P, Acampa O, Corradi M, Bergonzi R, Apostoli P and Mutti A 2004 Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten Environ. Health Perspect. 112 1293-8 (Pubitemid 39294967)
24. Goldoni M, Caglieri A, Poli D, Vettori M V, Corradi M, Apostoli P and Mutti A 2006 Determination of hexavalent chromium in exhaled breath condensate and environmental air among chrome plating workers Anal. Chim. Acta 562 229-35
25. Caglieri A, Goldoni M, Acampa O, Andreoli R, Vettori M V, Corradi M, Apostoli P and Mutti A 2006 The effect of inhaled chromium on different exhaled breath condensate biomarkers among chrome-plating workers Environ. Health Perspect. 114 542-6
26. Mutti A and Corradi M 2006 Recent developments in human biomonitoring: non-invasive assessment of target tissue dose and effects of pneumotoxic metals Med. Lav. 97 199-206
27. Mastruzzo C, Crimi N and Vancheri C 2002 Role of oxidative stress in pulmonary fibrosis Monaldi Arch. Chest Dis. 57 173-6
28. Nemery B et al 2001 Interstitial lung disease induced by exogenous agents: factors governing susceptibility Eur. Respir. J. 18 (Suppl 32) 30s-42s
29. Boots A W, Drent M, Swennen E L, Moonen H J, Bast A and Haenen G R 2009 Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants Respir. Med. 103 364-72
30. Travis W D et al 2008 Idiopathic nonspecific interstitial pneumonia: report of an American thoracic society project Am. J. Respir. Crit. Care Med. 177 1338-47
31. ATS/ERS/WASOG Committee 1999 Statement on sarcoidosis Am. J. Respir. Crit. Care Med. 160 736-55
32. Costabel U 2001 Sarcoidosis: clinical update Eur. Respir. J. 18 (Suppl. 32) 56s-68s
33. Corradi M, Acampa O, Goldoni M, Andreoli R, Milton D, Sama S R, Rosiello R, de Palma G, Apostoli P and Mutti A 2009 Metallic elements in exhaled breath condensate and serum of patients with exacerbation of chronic obstructive pulmonary disease Metallomics 1 339-45
34. Monsó E, Tura J M, Marsal M, Morell F, Pujadas J and Morera J 1990 Mineralogical microanalysis of idiopathic pulmonary fibrosis Arch. Environ. Health 45 185-8
35. Kitamura H, Ichinose S, Hosoya T, Ando T, Ikushima S, Oritsu M and Takemura T 2007 Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis-elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases Pathol. Res. Pract. 203 575-85
36. Siegesmund K A, Funahashi A and Pinter K 1974 Identification of metals in lung from a patient with interstitial pneumonia Arch. Environ. Health 28 345-9
37. Rizzato G, Lo Cicero S, Barberis M, Torre M, Pietra R and Sabbioni E 1986 Trace of metal exposure in hard metal lung disease Chest 90 101-6
38. Thannickal V J, Toews G B, White E S, Lynch J P and Martinez F J 2004 Mechanism of pulmonary fibrosis Annu. Rev. Med. 55 395-417
39. Bargagli E, Monaci F, Bianchi N, Bucci C and Rottoli P 2008 Analysis of trace elements in bronchoalveolar lavage of patients with diffuse lung diseases Biol. Trace Elem. Res. 124 225-35
40. Corradi M, Pignatti P, Brunetti G, Goldoni M, Caglieri A, Nava S, Moscato G and Balbi B 2008 Comparison between exhaled and bronchoalveolar lavage levels of hydrogen peroxide in patients with diffuse interstitial lung diseases Acta Biomed. 79 (Suppl 1) 73-8